Pancreatic Cancer Trial, Recruiting NCT07232810 Sponsor: Minia University Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT07232810
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who are scheduled to have a specific type of pancreatic surgery called a pancreaticoduodenectomy, which involves removing part of the pancreas and surrounding tissue
  • People who have been diagnosed with pancreatic cancer in the head of the pancreas, confirmed through a biopsy taken during an internal scan procedure
  • People whose cancer is considered removable by surgery, meaning it has not spread to distant parts of the body, is not wrapping around major arteries beyond a certain point, and any affected veins can be repaired
  • People who are reasonably physically well and able to carry out daily activities, as assessed by a standard medical scale (confirm with trial site)
  • People whose liver and kidney function meet certain minimum levels as measured by blood tests
  • People who are willing and able to give written agreement to take part in the trial

Who may not be able to join:

  • People whose cancer cannot be surgically removed
  • People whose cancer has spread to distant parts of the body
  • People whose tumour is located near the pancreas but is not specifically pancreatic cancer (confirm with trial site)
  • People who have already received chemotherapy or radiation treatment before surgery for this cancer
  • People who currently have another active cancer
  • People with serious health conditions that would make surgery too risky, such as uncontrolled heart disease
  • People who are pregnant or currently breastfeeding
  • People who have previously had radiation treatment to the abdomen area
  • People who are unwilling or unable to give informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Saleh K Saleh, MD, Minia University

Phone: 01201765401

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Minia University
Registry
ClinicalTrials.gov
Start date
1 December 2025
Est. completion
1 December 2027

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Disease-Free Survival (DFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov